IFNG and lung carcinoma: In this study, we show that IFN-γ-modified MSCs continuously express TRAIL and induce apoptosis in lung cancer cells by activating caspase-3 within the target cells. In vivo models further confirm the antitumor effect of the IFN-γ-secreting MSCs.